Cargando…
Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance
BACKGROUND & AIMS: Induction of potent, HBV-specific immune responses is crucial to control and finally cure HBV. The therapeutic hepatitis B vaccine TherVacB combines protein priming with a Modified Vaccinia virus Ankara (MVA)-vector boost to break immune tolerance in chronic HBV infection. Par...
Autores principales: | Sacherl, Julia, Kosinska, Anna D., Kemter, Kristina, Kächele, Martin, Laumen, Sabine C., Kerth, Hélène A., Öz, Edanur Ates, Wolff, Lisa S., Su, Jinpeng, Essbauer, Sandra, Sutter, Gerd, Scholz, Martin, Singethan, Katrin, Altrichter, Jens, Protzer, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880034/ https://www.ncbi.nlm.nih.gov/pubmed/36714793 http://dx.doi.org/10.1016/j.jhepr.2022.100603 |
Ejemplares similares
-
Mechanistic principles of an ultra-long bovine CDR reveal strategies for antibody design
por: Svilenov, Hristo L., et al.
Publicado: (2021) -
Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants
por: Svilenov, Hristo L., et al.
Publicado: (2022) -
Depletion of T cells via Inducible Caspase 9 Increases Safety of Adoptive T-Cell Therapy Against Chronic Hepatitis B
por: Klopp, Alexandre, et al.
Publicado: (2021) -
PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis B
por: Bunse, Till, et al.
Publicado: (2022) -
Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection
por: Kosinska, Anna D., et al.
Publicado: (2019)